South San Francisco biotech files for what could be first Bay Area IPO of 2019
December 28, 2018 at 09:41 AM EST
Harpoon Therapeutics is developing proteins to direct infection-fighting T cells to better identify and attack tumor cells.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.